Philip Bonomi to Proto-Oncogene Proteins c-bcl-2
This is a "connection" page, showing publications Philip Bonomi has written about Proto-Oncogene Proteins c-bcl-2.
Connection Strength
0.294
-
Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer. Clin Cancer Res. 2012 Jun 01; 18(11):3163-9.
Score: 0.103
-
Apoptosis. J Thorac Oncol. 2009 Nov; 4(11 Suppl 3):S1061-2.
Score: 0.087
-
Increased cytosol Ca(2+) and type 1 programmed cell death in Bcl-2-positive U937 but not in Bcl-2-negative PC-3 and Panc-1 cells induced by the 5-lipoxygenase inhibitor MK 886. Prostaglandins Leukot Essent Fatty Acids. 2002 Apr; 66(4):443-52.
Score: 0.051
-
Potential applications of apoptosis in modifying the biological behavior of therapeutically refractory cancers. Med Hypotheses. 1994 Oct; 43(4):207-13.
Score: 0.031
-
Altered oncogene, tumor suppressor and cell-cycle gene expression in PANC-1 cells cultured with the pleiotrophic 5-lipoxygenase inhibitor, MK886, assessed with a gene chip. Anticancer Res. 1999 Sep-Oct; 19(5B):3873-87.
Score: 0.011
-
Does maximizing programmed cell death necessarily yield an optimum clinical advantage? Med Hypotheses. 1999 Mar; 52(3):235-8.
Score: 0.010